Our previous work has established the utility of gene targeting via traditional homologous recombination (HR) to genetically correct the expanded disease causing polyglutamine (polyQ) mutation within exon 1 of the huntingtin (HTT) gene in HD patient-derived iPSCs 9. Here, HTT is linked to Huntington disease.